GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (NYSE:ALC) » Definitions » Forward PE Ratio
中文

Alcon (ALC) Forward PE Ratio : 25.70 (As of Apr. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Alcon Forward PE Ratio?

Alcon's Forward PE Ratio for today is 25.70.

Alcon's PE Ratio without NRI for today is 29.04.

Alcon's PE Ratio for today is 40.60.


Alcon Forward PE Ratio Historical Data

The historical data trend for Alcon's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon Forward PE Ratio Chart

Alcon Annual Data
Trend 2019-12 2020-12 2021-12 2022-12 2023-12 2024-04
Forward PE Ratio
28.09 34.25 36.23 27.17 24.75 25.84

Alcon Quarterly Data
2019-06 2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 31.15 26.88 28.09 26.04 41.49 28.01 34.25 39.22 37.04 37.31 36.23 31.95 28.41 22.32 27.17 27.40 30.86 25.13 24.75 27.55

Competitive Comparison of Alcon's Forward PE Ratio

For the Medical Instruments & Supplies subindustry, Alcon's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alcon's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alcon's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Alcon's Forward PE Ratio falls into.



Alcon Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Alcon  (NYSE:ALC) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Alcon Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Alcon's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alcon (ALC) Business Description

Traded in Other Exchanges
Address
Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.